Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PCI and Experic are with a strategic, synergistic partnership involving clinical and commercial manufacturing, packaging and supply chain services.
read more
Sygnature Discovery has acquired of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes in vivo services for biotechs, pharmaceutical companies and academics.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna to create a new generation of transformative medicines for patients.
read more
Avectas has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in the characterization of cells engineered with Avectas' proprietary, non-viral SOLUPORE™ cell engineering platform.
read more
Vectura announced three appointments to its business development team.
read more
CURE Pharmaceutical announced a collaboration with PMI, a subsidiary of Factoria Bogar in Guadalajara, Mexico.
read more
IonSense and WHALE Biolabs announced a strategic alliance to provide analytical services for chemists utilizing HTE in their laboratories.
read more
The FDA is making its previously developed MyStudies app available to investigators to obtain informed consent securely from patients for eligible clinical trials when face-to-face contact is not possible or practical due to COVID-19 control measures...
read more
ERT announced the results of a recent industry survey that indicate an acceleration in the adoption of virtual clinical trials due to the COVID-19 pandemic.
read more
Flamma announced the ground breaking for their new R&D building.
read more
Octapharma USA is extending funding for an IIS focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
read more
Mylan and Lupin announced that the EC has granted marketing authorization for Nepexto, a biosimilar to Enbrel.
read more
Almac Group has welcomed confirmation from the EU’s medicines regulator, the EMA, that, post-Brexit, Northern Ireland will remain in regulatory alignment with the EU.
read more
Jounce Therapeutics has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb.
read more
Celerion has announced the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America.
read more